• Теги
    • избранные теги
    • Компании65
      • Показать ещё
      Разное48
      • Показать ещё
      Страны / Регионы32
      • Показать ещё
      Формат1
      Международные организации3
      Сферы1
Выбор редакции
17 ноября, 16:11

CR Bard (BCR) Sees Hammer Chart Pattern: Time to Buy?

CR Bard Inc. (BCR) has been struggling lately, but the selling pressure may be coming to an end soon.

26 октября, 17:21

C.R. Bard (BCR) Beats Q3 Earnings & Sales, FY16 View Up

C.R. Bard Inc. (BCR) reported adjusted earnings of $2.64 in the third quarter of 2016, exceeding the Zacks Consensus Estimate by 9 cents and also improving 15.8% from the year-ago quarter.

Выбор редакции
24 октября, 23:19

C.R. Bard (BCR) to Report Q3 Earnings: What's in the Cards?

CR Bard Inc. (BCR) is scheduled to report third-quarter 2016 earnings on Oct 25.

Выбор редакции
20 сентября, 15:49

CR Bard (BCR) Gets FDA's IDE Approval for Lutonix DCB

CR Bard Inc. (BCR) recently announced the receipt of an Investigational Device Exemption (IDE) approval from the U.S. FDA for its Lutonix 014 Drug Coated Balloon (DCB) to extend the primary endpoint of the product to a 6-month time frame.

28 июля, 16:45

CONMED (CNMD) Earnings & Sales Beat in Q2, '16 View Up

CONMED Corporation (CNMD) reported second-quarter 2016 adjusted earnings of 47 cents per share, surpassing the Zacks Consensus Estimate.

27 июля, 22:19

C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up

C.R. Bard Inc. (BCR) reported adjusted earnings of $2.56 in the second quarter of 2016, exceeding the Zacks Consensus Estimate by a dime.

27 июля, 20:16

LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom

LabCorp (LH) reported a solid second quarter 2016 with adjusted earnings per share (EPS) of $2.31, up 10.5% from the year-ago quarter.

22 июля, 15:34

Varian (VAR): What's in Store for the Stock in Q3 Earnings?

We expect Varian Medical Systems Inc. to beat earnings when it reports third-quarter 2016 results on Jul 27.

Выбор редакции
21 июля, 15:30

Should You Buy CR Bard (BCR) Ahead of Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and CR Bard Inc.(BCR) may be one such company

18 июля, 22:27

Will LabCorp (LH) Beat Earnings Estimates in Q2?

We expect Laboratory Corp. of America Holdings (LH), or LabCorp to beat expectations when it reports second-quarter 2016 results before the opening bell on Jul 27.

08 июля, 15:18

VWR Corp Poised on Balanced Growth, Strong Fundamentals

On Jul 7, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).

05 июля, 16:29

CR Bard: Expansion Plans on Track, Product Pipeline Strong

CR Bard had a robust performance in international markets, extensive expenditure on product innovation and a diversified product portfolio.

30 июня, 15:27

CR Bard (BCR) at 52-Week High on Strong Product Pipeline

Shares of CR Bard (BCR) rallied to a new 52-week high of $232.77 on Jun 29.

21 июня, 14:00

LabCorp Sees Balanced Growth; Covance Synergy on Track

On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).

17 мая, 15:07

LabCorp (LH) Posts Strong Q1; Covance Synergy Continues

On May 16, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).

28 апреля, 16:16

C.R. Bard (BCR) Beats Q1 Earnings & Sales, FY16 View Up

C.R. Bard Inc. (BCR) reported adjusted earnings of $2.34 in the first quarter of 2016, exceeding the Zacks Consensus Estimate by 17 cents.

Выбор редакции
23 октября 2015, 17:20

C.R. Bard (BCR) Beats on Q3 Earnings & Sales, Guides Up

C.R. Bard Inc. (BCR) reported adjusted earnings of $2.28 in the third quarter of 2015, which exceeded the Zacks Consensus Estimate by 4 cents.

28 сентября 2015, 20:25

LabCorp Well Poised on Covance Buyout, Strategic Alliances

On Sep 25, 2015, we issued an updated research report on Laboratory Corporation of America Holdings (LH).

Выбор редакции
25 сентября 2015, 16:32

Strength Seen in Steris (STE): Stock Moves 8% Higher

Steris Corp. (STE) was a big mover last session, as the company saw its shares rise more than 8% on the day.